Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / settlement-authority-memo.docx
settlement-authority-memo.docx
Parties
Harkness LLP
Solstice Biomedical Devices Ltd
Ridgeline IP Analytics LLC
Bennington LLP
Pinnacle Economics Group LLC
Keystone Valuation Advisors LLC
Lau LLP
See Georgia-Pacific Corp
Dates
May 9, 2024
December 6, 2024
March 17, 2025
September 30, 2025
November 14, 2017
June 22, 2035
April 30, 2019
September 15, 2036
March 2, 2021
January 10, 2038
Amounts
$22
$4.5
$7,000,000
$10,000,000
$8,500,000
$9,000,000
$312
€187.4
$74.6
$31.8
Obligations
Most-Favored Licensee Clause Calderwood & Harkness recommends seeking a most-favored licensee ("MFN") clause in the settlement agreement, providing that if Apex subsequently grants a license under the asserted patents (or the broader Apex Trocar Patent Family) to any third party at a royalty rate lower than the rate granted to Solstice, Apex must promptly reduce Solstice's rate to match the lower rate